| Product Information |
|
| Registration Number |
DR-XY48382
|
| Generic Name |
Bupropion Hydrochloride + Naltrexone Hydrochloride
|
| Brand Name |
Contrave
|
| Dosage Strength |
90 mg/ 8 mg
|
| Dosage Form |
Extended Release Tablet
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
Anti-Obesity Preparation
|
| Packaging |
White opaque HDPE bottle with PP child-resistant
closure x 120's (Box of 1 bottle)
|
| Manufacturer |
Patheon Inc.
|
| Country of Origin |
Canada
|
| Trader |
N/A
|
| Importer |
iNova Pharmaceuticals Philippines Inc.
|
| Distributor |
N/A
|
| Application Type |
Monitored Release
|
| Issuance Date |
30 September 2022
|
| Expiry Date |
30 September 2027
|